Best practice in decentralised trials
By removing logistical barriers, decentralised clinical trials (DCTs) offer time and cost savings, improved patient access, and more diverse and representative populations. Our latest report, Best Practices in Decentralised Trials, delves into the potential of decentralised clinical trials (DCTs) and offers actionable insights to help you navigate the evolving landscape. A detailed analysis of current trends, regulatory guidance, and expert opinions to help you navigate the complexities of DCTs. Covering a wide range of topics such as data privacy, patient engagement, digital endpoints, and remote monitoring, this report provides actionable insights for improving trial efficiency and patient experience.
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Biopharma’s implementation of DCTs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Best practices when implementing DCTs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Regulatory perspective on DCTs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Future opportunities for implementing DCTs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook